文献速递膀胱癌与上尿路尿路上皮癌

非肌层浸润性膀胱癌的性别差异:大型人群数据集的陷阱与整合分析的启示

Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis.
PubMed 文献 · Eur Urol Oncol · 2024-10-23

研究整合SEER-Medicare与UROMOL数据集探讨非肌层浸润性膀胱癌的性别差异。SEER-Medicare队列中女性复发和进展风险低于男性,但膀胱癌特异性死亡率无显著差异。UROMOL队列基因组、转录组和空间蛋白质组分析未发现肿瘤生物学性别差异,提示需结合人群数据与分子生物学结果全面理解该病。

要点

  • SEER-Medicare队列中女性非肌层浸润性膀胱癌复发和进展风险低于男性。
  • SEER-Medicare队列中男女膀胱癌特异性死亡率无显著差异。
  • UROMOL队列基因组、转录组和空间蛋白质组分析未发现肿瘤生物学性别差异。

核心结论

  • 仅依赖SEER-Medicare数据识别非肌层浸润性膀胱癌真实复发率和进展率存在局限。
  • 整合人群数据与分子生物学结果有助于全面理解非肌层浸润性膀胱癌的性别差异。

研究设计与样本

  • 整合分析,使用SEER-Medicare和UROMOL数据集探索非肌层浸润性膀胱癌肿瘤学结局的性别差异。

主要发现

  • SEER-Medicare队列中女性复发风险低于男性,进展风险也低于男性。
  • SEER-Medicare队列中男女膀胱癌特异性死亡率无显著差异。
  • UROMOL队列基因组、转录组和空间蛋白质组分析未发现肿瘤生物学的性别特异性差异。

局限性

  • 仅依赖SEER-Medicare数据识别非肌层浸润性膀胱癌真实复发率和进展率具有挑战性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The impact of sex on non-muscle-invasive bladder cancer (NMIBC) remains uncertain and current evidence is conflicting. To address this uncertainty, we conducted an integrative analysis using Surveillance, Epidemiology and End Results (SEER)-Medicare and UROMOL data sets to explore sex disparities in NMIBC oncological outcomes. In the SEER-Medicare cohort, females had lower risks of recurrence and progression in comparison to males, but no significant difference in BC-specific mortality was observed. Analysis of the UROMOL cohort revealed no sex-specific differences in tumour biology across genomic, transcriptomic, and spatial proteomic domains. These findings highlight the limitations of relying on just SEER-Medicare data for NMIBC, for which identification of the true incidence of recurrence and progression is challenging, and emphasise the importance of combining population-based data and molecular biology results to gain a comprehensive understanding of NMIBC. PATIENT SUMMARY: The impact of sex on non-muscle-invasive bladder cancer (NMIBC) outcomes is unclear. Our analysis of a large population-based data set showed that the risks of recurrence and progression were lower for females. However, analysis of a separate molecular dataset showed no sex-specific differences. The results highlight the importance of combining population-based data and molecular biology results for a better understanding of NMIBC.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Lobo N, Duan Z, Sood A, et al. Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis. Eur Urol Oncol. 2024. PMID: 39448349. doi:10.1016/j.euo.2024.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。